Skip to content

APOTHEEK CREMERS: what changed

BE 0405.238.977NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€22,106
2024 · €174,693-€152,586
Equity
€650,926
2024 · €628,820+€22,106
Cash
€172,537
2024 · €95,694+€76,844
Balance sheet total
€1.3m
2024 · €1.3m+€15,429

Largest movements

2024 to 2025
Assets
  • Cash +€76,844

    up €76,844 (+80.3%), from €95,694 to €172,537

    mainly Depreciation (+€66,025) and Tax, wage and social debts (+€32,740)

  • Receivables within one year -€28,795

    down €28,795 (-11.9%), from €241,166 to €212,371

    of which Other amounts receivable: -€28,874

  • Stocks and contracts -€22,823

    down €22,823 (-6.1%), from €373,194 to €350,371

  • Tangible fixed assets -€19,521

    down €19,521 (-3.8%), from €508,293 to €488,772

    of which Plant, machinery and equipment: -€30,486

Equity and liabilities
  • Debts after one year -€52,462

    down €52,462 (-17.9%), from €293,857 to €241,395

  • Tax, wage and social debts +€32,740

    up €32,740 (+102%), from €32,123 to €64,863

    of which Taxes: +€23,885

  • Trade debts +€32,611

    up €32,611 (+22.0%), from €148,347 to €180,958

  • Reserves +€22,106

    up €22,106 (+3.9%), from €567,320 to €589,426

    of which Distributable reserves: +€22,106

  • Other debts -€20,103

    down €20,103 (-19.9%), from €101,234 to €81,131

Income statement
  • Taxes +€57,929

    up €57,929 (+965%), from €6,005 to €63,934

  • Gross operating margin -€45,408

    down €45,408 (-10.6%), from €427,797 to €382,389

  • Staff costs +€33,419

    up €33,419 (+19.1%), from €175,427 to €208,846

  • Depreciation +€10,241

    up €10,241 (+18.4%), from €55,785 to €66,025

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €174,693
Gross operating margin -€45,408
Staff costs -€33,419
Depreciation -€10,241
Other operating charges +€121
Other operating items +€151
Financial income -€2,121
Financial charges -€3,741
Taxes -€57,929
Result 2025 €22,106
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€186,525
Investment -€57,518
Financing -€52,163
Cash 2024 €95,694
Net result for the year +€22,106
Depreciation +€66,025
Stocks and contracts +€22,823
Receivables within one year +€28,795
Deferred charges and accrued income +€1,289
Trade debts +€32,611
Tax, wage and social debts +€32,740
Other debts -€20,103
Accrued charges and deferred income +€238
Investment in fixed assets (net) -€57,518
Debts after one year -€52,462
Current portion of long-term debt +€299
Cash 2025 €172,537
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,256,543 €1,271,972 +€15,429 +1.2%
Fixed assets 21/28 €542,952 €534,446 -€8,507 -1.6%
Intangible fixed assets 21 €34,659 €45,673 +€11,014 +31.8%
Tangible fixed assets 22/27 €508,293 €488,772 -€19,521 -3.8%
Land and buildings 22 €384,783 €379,927 -€4,856 -1.3%
Plant, machinery and equipment 23 €123,224 €92,737 -€30,486 -24.7%
Furniture and vehicles 24 €287 €16,108 +€15,821 +5,518%
Current assets 29/58 €713,591 €737,527 +€23,936 +3.4%
Stocks and contracts in progress 3 €373,194 €350,371 -€22,823 -6.1%
Stocks 30/36 €373,194 €350,371 -€22,823 -6.1%
Amounts receivable within one year 40/41 €241,166 €212,371 -€28,795 -11.9%
Trade receivables 40 €163,292 €163,371 +€79 0.0%
Other amounts receivable 41 €77,874 €49,000 -€28,874 -37.1%
Cash at bank and in hand 54/58 €95,694 €172,537 +€76,844 +80.3%
Deferred charges and accrued income 490/1 €3,537 €2,248 -€1,289 -36.4%
Total equity and liabilities 10/49 €1,256,543 €1,271,972 +€15,429 +1.2%
Equity 10/15 €628,820 €650,926 +€22,106 +3.5%
Contributions 10/11 €61,500 €61,500 = 0.0%
Capital 10 €61,500 €61,500 = 0.0%
Issued capital 100 €61,500 €61,500 = 0.0%
Reserves 13 €567,320 €589,426 +€22,106 +3.9%
Non-distributable reserves 130/1 €6,150 €6,150 = 0.0%
Legal reserve 130 €6,150 €6,150 = 0.0%
Distributable reserves 133 €561,170 €583,276 +€22,106 +3.9%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €627,723 €621,046 -€6,677 -1.1%
Amounts payable after more than one year 17 €293,857 €241,395 -€52,462 -17.9%
Financial debts 170/4 €293,857 €241,395 -€52,462 -17.9%
Amounts payable within one year 42/48 €333,867 €379,414 +€45,547 +13.6%
Current portion of amounts payable after more than one year 42 €52,163 €52,462 +€299 +0.6%
Trade debts 44 €148,347 €180,958 +€32,611 +22.0%
Suppliers 440/4 €148,347 €180,958 +€32,611 +22.0%
Taxes, remuneration and social security 45 €32,123 €64,863 +€32,740 +102%
Taxes 450/3 €2,667 €26,552 +€23,885 +896%
Remuneration and social security 454/9 €29,456 €38,311 +€8,855 +30.1%
Other amounts payable 47/48 €101,234 €81,131 -€20,103 -19.9%
Accrued charges and deferred income 492/3 - €238 +€238
Remuneration, social security and pensions 62 €175,427 €208,846 +€33,419 +19.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €55,785 €66,025 +€10,241 +18.4%
Other operating charges 640/8 €5,405 €5,283 -€121 -2.2%
Non-recurring operating charges 66A €151 €0 -€151 -100%
Gross operating margin 9900 €427,797 €382,389 -€45,408 -10.6%
Operating profit (loss) 9901 €191,029 €102,234 -€88,796 -46.5%
Financial income 75/76B €4,097 €1,976 -€2,121 -51.8%
Recurring financial income 75 €4,097 €1,976 -€2,121 -51.8%
Financial charges 65/66B €14,429 €18,169 +€3,741 +25.9%
Recurring financial charges 65 €14,429 €18,169 +€3,741 +25.9%
Profit (loss) for the period before taxes 9903 €180,697 €86,040 -€94,657 -52.4%
Income taxes 67/77 €6,005 €63,934 +€57,929 +965%
Profit (loss) for the period 9904 €174,693 €22,106 -€152,586 -87.3%
Profit (loss) for the period to be appropriated 9905 €174,693 €22,106 -€152,586 -87.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€685,158 to €838,171

Midpoint €748,914 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €605,253
Capitalised earnings €765,064 to €1.1m
Indication €685,158 to €838,171

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€650,926
Intangible fixed assets (21)
-€45,673
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€605,253

Capitalised earnings

net result for the year (9904)
2025
€22,106
2024
€174,693
excluding non-recurring income and charges
€174,844
2023
€124,377
2022
€81,404
2021
€95,124
Average result, excluding non-recurring income and charges
€107,109
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€765,064 / €892,575 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 12 November 2026 via checked.be.